Metabolism and macromolecular binding of 1-nitronaphthalene in the mouse.

[1]  R. Rasmussen,et al.  Comparative cytotoxicity of naphthalene and its monomethyl‐ and mononitro‐derivatives in the mouse lung , 1986, Journal of applied toxicology : JAT.

[2]  F. Beland,et al.  1-Nitrosopyrene: an intermediate in the metabolic activation of 1-nitropyrene to a mutagen in Salmonella typhimurium TA1538. , 1985, Mutation research.

[3]  J. A. Bond,et al.  Metabolism and macromolecular covalent binding of [14C]-1-nitropyrene in isolated perfused and ventilated rat lungs. , 1984, Cancer research.

[4]  E. Mimnaugh,et al.  Selective damage to nonciliated bronchiolar epithelial cells in relation to impairment of pulmonary monooxygenase activities by 1,1-dichloroethylene in mice. , 1984, Toxicology and applied pharmacology.

[5]  T. Devereux.  Alveolar type II and Clara cells: isolation and xenobiotic metabolism. , 1984, Environmental health perspectives.

[6]  J. Bond.  Bioactivation and biotransformation of 1-nitropyrene in liver, lung and nasal tissue of rats. , 1983, Mutation research.

[7]  A. Buckpitt,et al.  Evidence for hepatic formation, export and covalent binding of reactive naphthalene metabolites in extrahepatic tissues in vivo. , 1983, The Journal of pharmacology and experimental therapeutics.

[8]  D. Brown,et al.  Evidence for cytochrome P-450 mediated metabolism in the bronchiolar damage by naphthalene. , 1982, Chemico-biological interactions.

[9]  R. Breger,et al.  Pulmonary toxicity, hepatic, and extrahepatic metabolism of 2-methylnaphthalene in mice. , 1981, Toxicology and applied pharmacology.

[10]  J. Crivello.  Nitrations and oxidations with inorganic nitrate salts in trifluoroacetic anhydride , 1981 .

[11]  T. Devereux,et al.  Isolation of pulmonary cells and use in studies of xenobiotic metabolism. , 1981, Methods in enzymology.

[12]  M. Boyd,et al.  The pulmonary clara cell as a target for toxic chemicals requiring metabolic activation; studies with carbon tetrachloride. , 1980, The Journal of pharmacology and experimental therapeutics.

[13]  H. Cornish,et al.  Metabolic conversion of 1- and 2-nitronaphthalene to 1- and 2-naphthylamine in the rat. , 1978, Toxicology and applied pharmacology.

[14]  F. A. Patty,et al.  Patty's Industrial hygiene and toxicology , 1978 .

[15]  M. Boyd.  Evidence for the Clara cell as a site of cytochrome P450-dependent mixed-function oxidase activity in lung , 1977, Nature.

[16]  D. Mahvi,et al.  Morphology of a naphthalene-induced bronchiolar lesion. , 1977, The American journal of pathology.

[17]  R. Mason,et al.  The role of catalytic superoxide formation in the O2 inhibition of nitroreductase. , 1975, Biochemical and biophysical research communications.

[18]  G. Krishna,et al.  Metabolism and binding of aromatic hydrocarbons in the lung. Relationship to experimental bronchiolar necrosis. , 2015, The American review of respiratory disease.

[19]  M. Kaighn.  Human Liver Cells , 1973 .

[20]  H. J. Phillips.  Dye Exclusion Tests for Cell Viability , 1973 .

[21]  F. Oesch,et al.  Hepatic epoxide hydrase. Structure-activity relationships for substrates and inhibitors. , 1971, Biochemistry.

[22]  M. Karnovsky,et al.  A formaldehyde-glutaraldehyde fixative of high osmolality for use in electron-microscopy , 1965 .

[23]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[24]  W. C. Schneider,et al.  Intracellular distribution of enzymes; the oxidation of octanoic acid by rat liver fractions. , 1948, The Journal of biological chemistry.